These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9851186)

  • 61. Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma.
    Ribatti D; Nico B; Vacca A
    Oncogene; 2006 Jul; 25(31):4257-66. PubMed ID: 16518413
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multiple myeloma: recognition and management.
    George ED; Sadovsky R
    Am Fam Physician; 1999 Apr; 59(7):1885-94. PubMed ID: 10208707
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multiple myeloma: primary bone tumor with systemic manifestations.
    Bilsky MH; Azeem S
    Neurosurg Clin N Am; 2008 Jan; 19(1):31-40. PubMed ID: 18156045
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Wnt antagonism in multiple myeloma: a potential cause of uncoupled bone remodeling.
    Pearse RN
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6274s-6278s. PubMed ID: 17062713
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Hyperammonemia during hypothyroidism: an unusual biohumoral finding normalized by hormonal replacement treatment].
    De Nardo D; Franconi G; Sabino D
    Ann Ital Med Int; 1999; 14(3):196-201. PubMed ID: 10566186
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Multiple myeloma: the role of angiogenesis and therapeutic application of thalidomide].
    Jurczyszyn A; Wolska-Smoleń T; Skotnicki AB
    Przegl Lek; 2003; 60(8):542-7. PubMed ID: 14974349
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Inherited hyperammonemia].
    Bik-Multanowski M
    Przegl Lek; 1998; 55(6):337-41. PubMed ID: 9857711
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of markers of bone remodeling in multiple myeloma.
    Terpos E; Politou M; Rahemtulla A
    Blood Rev; 2005 May; 19(3):125-42. PubMed ID: 15748961
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Multiple myeloma with hyperammonemia].
    Izumi T
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):446-8. PubMed ID: 9851186
    [No Abstract]   [Full Text] [Related]  

  • 70. Ammonia toxicity to the brain and creatine.
    Bachmann C; Braissant O; Villard AM; Boulat O; Henry H
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S52-7. PubMed ID: 15050974
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pathophysiology of multiple myeloma bone disease.
    Lentzsch S; Ehrlich LA; Roodman GD
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1035-49, viii. PubMed ID: 17996587
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Complications of multiple myeloma.
    Bladé J; Rosiñol L
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1231-46, xi. PubMed ID: 17996596
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The clinical significance of M proteins].
    Sasaki R
    Rinsho Byori; 2001 Jul; 49(7):678-81. PubMed ID: 11519130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 4.